All News

Researchers explored the effectiveness of telephonic insulin titration by a clinical pharmacist compared with in-office titration among patients in a medical residency clinic.

Brett Barker, PharmD, state representative in Iowa’s 51st District, joined Drug Topics to discuss significant implications and common misconceptions regarding Iowa’s new PBM bill.

Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates in patients with an A1c level less than 7% compared with common daily insulin.

The therapy is now the first and only oral on-demand treatment option for the condition.

Researchers determined the impact COVID-19 interventions had on Danish children’s incidence of RSV, influenza, and invasive pneumococcal disease.

This year’s conference is taking place from July 10 to 13 in Nashville, Tennessee.

Brett Barker, PharmD, State Representative in Iowa’s 51st District, discussed Senate File 383 and how it’s intended to impact Iowa pharmacies.

Investigators also report that sodium-glucose cotransporter 2 inhibitors are not associated with thrombotic risk.

Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

As state-level PBM reform heats up amid dire situations for many retail pharmacies, Walgreens Chief Pharmacy Officer Rick Gates joins Drug Topics to discuss ongoing industry challenges.

Patients who used the Bigfoot Unity Diabetes Management System had glycemic control and reduced diabetes distress.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.

This episode explores how pharmacists can navigate their careers with clarity and purpose by grounding themselves in their professional oath, organizational mission, and core values.

As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.

In part 3 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explores the future of pharmacy practices and how modern use of technologies like AI are becoming commonplace.

Researchers explored patients with type 1 diabetes and overweight or obesity to understand the efficacy and safety of GLP-1s as adjunctive therapies.

In a recap of his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter, RPh, discussed the role of pharmacists in team-based diabetes care.

Taylor Watterson, PharmD, PhD, discusses how pharmacy technician burnout can impact pharmacy operations.

Rob Frankil, RPh, discusses how independent pharmacies in Pennsylvania are dealing with the impact of Rite Aid stores closing.

Pharmacist-led deprescribing can help reduce the number of medications a patient is taking in an effective way.

Interest in community pharmacy practice is declining as pharmacists seek roles with better work-life balance, greater autonomy, and more meaningful patient care opportunities.

Walgreens Chief Pharmacy Officer Rick Gates discusses ongoing movement at the state level regarding pharmacy benefit manager reform.

In an abstract presented at the American Diabetes Association 85th Scientific Sessions, researchers tested the effectiveness of an AI-driven program for improving glycemic control.

Jon Easter, RPh, discusses pharmacists’ ability to improve patient engagement in diabetes care following his presentation at the American Diabetes Association’s 85th Scientific Sessions.

Pharmacists play a role in educating patients as well as making them feel more comfortable when utilizing opioid use treatment.

Rick Gates, chief pharmacy officer at Walgreens and chairman of the National Association of Chain Drug Stores, discussed the current status of retail pharmacies and the way they are reimbursed.